Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PCRX
#2109
Pacira BioSciences, Inc. Common Stock
21.910
0
-5.88%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-5.88%
Monthly Change
+10.54%
6 month change
+0.37%
Year Change
+0.37%
Previous Close
23.280
0
Open
21.910
0
Bid
Ask
Low
21.910
0
High
21.910
0
Volume
171
Markets
US Stock Market
Healthcare
PCRX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.86 M
44.85 M
45.95 M
46.5 M
46.28 M
40.49 M
—
Valuation ratios
Enterprise value
2.52 B
2.11 B
1.68 B
1.33 B
595.07 M
889.33 M
3.49 B
Price to earnings ratio
17.97
65.4
114.29
35.96
-8.76
161.75
194.53
Price to sales ratio
6.08
5.07
2.71
2.46
119.65
—
—
Price to cash flow ratio
33.93
21.84
12.45
10.76
4.6
7.67
30.88
Price to book ratio
4.22
3.76
2.33
1.91
1.12
1.68
2.79
Enterprise value to EBITDA ratio
8.64
6.03
4.07
2.8
-1.67
—
—
Profitability ratios
Return on assets %
0.11
0.02
0.01
0.03
-0.06
0.01
-0.01
Return on equity %
0.23
0.06
0.02
0.05
-0.13
0.01
-0.02
Return on invested capital %
-155.42
22.44
13.41
19.05
-11.09
3.31
0.87
Gross margin %
72.69
74.1
70.11
72.64
-2 240.4
79.39
317.56
Operating margin %
10.79
16.61
9
12.99
-1 007.57
2.64
10.6
EBITDA margin %
68.05
64.67
61.97
70.6
-4 903.28
13.36
23.17
Net margin %
33.87
7.75
2.39
6.22
-1 367.21
0.97
-6.26
Liquidity ratios
Quick ratio
2.32
1.47
2.72
4.17
2
3.28
10.96
Current ratio
2.57
1.66
3.37
5.24
2.4
4.54
14.6
Inventory turnover
—
—
—
—
—
0.01
—
Asset turnover
0.41
0.32
0.36
0.41
0
0.52
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.33
0.39
0.33
0.25
0.29
1.07
Long term debt to total equity ratio
0.51
0.92
0.85
0.59
0.49
0.54
2.03
Per share metrics
Operating cash flow per share
1.76
2.76
3.12
2.98
4.1
3.37
3.32
EBIT per share
6.24
7.05
6.91
7.71
-9.42
0.13
-1.24
EBITDA per share
6.69
7.68
8.88
9.17
-7.72
2.15
0.75
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.94
14.39
6.2
5.36
10.48
5.29
31.01
Net current asset value per share
14.92
18.98
10.71
9.81
16.11
12.17
57.06
Tangible book value per share
9.7
-0.85
1.53
4.3
7.62
6.77
28.08
Working capital per share
9.12
7.56
7.53
7.94
9.41
9.49
38.45
Book value per share
14.19
16.01
16.65
16.74
16.83
15.39
64.98
News
Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)
Pacira BioSciences SVP Lauren Riker sells $83k in stock
Pacira BioSciences officer Williams sells $269k in shares
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Pacira BioSciences appoints Samit Hirawat to board of directors
Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why
Will Pacira (PCRX) Beat Estimates Again in Its Next Earnings Report?
Do Options Traders Know Something About Pacira BioSciences Stock We Don't?
44th Annual J.P. Morgan Healthcare Conference (NASDAQ:PCRX) 2026-01-14
PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific